Literature DB >> 17503302

The significance of steroid therapy after hepatoportoenterostomy in infants with biliary atresia.

S Shimadera1, N Iwai, E Deguchi, O Kimura, S Fumino, S Ono.   

Abstract

PURPOSE: Despite improvements in the surgical management of biliary atresia (BA), it is still difficult to maintain good bile flow. In the present study, we examined steroid therapy and determined the appropriate dose to achieve freedom from jaundice after hepatoportoenterostomy (HPE) in the uncorrectable type of BA.
METHODS: A retrospective clinical analysis was done in 23 of 29 (79 %) cases who had become jaundice-free after undergoing HPE with steroid therapy between 1988 and 2004. A correlation between the total or mean steroid dose and the postoperative jaundice period (serum total bilirubin > 1.0 mg/dl) was evaluated using linear regression analysis. The regimen was as follows: prednisolone was given intravenously, starting with 3 to 5 mg/kg/day, and then gradually tapered with repetition until freedom from jaundice was achieved.
RESULTS: Age at HPE was 72 +/- 20 days (mean +/- SD), and the postoperative jaundice period was 108 +/- 68 days. Total and mean steroid doses were 118 +/- 73 mg/kg and 1.31 +/- 0.8 mg/kg/day, respectively. There was no correlation between the total steroid dose and the period of jaundice. However, there was a significant correlation between the mean steroid dose and the period of jaundice (p = 0.021).
CONCLUSION: A high mean dose of steroids could shorten the jaundice period after HPE in the uncorrectable type of BA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503302     DOI: 10.1055/s-2007-965120

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  7 in total

1.  Corticosteroid treatment in biliary atresia: Tonic or toast?

Authors:  Ronald J Sokol
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 2.  Does adjuvant steroid therapy post-Kasai portoenterostomy improve outcome of biliary atresia? Systematic review and meta-analysis.

Authors:  Ahmed Sarkhy; Richard A Schreiber; Ruth A Milner; Collin C Barker
Journal:  Can J Gastroenterol       Date:  2011-08       Impact factor: 3.522

Review 3.  Recent advances in the pathogenesis and management of biliary atresia.

Authors:  Jessica A Zagory; Marie V Nguyen; Kasper S Wang
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

Review 4.  Biliary atresia.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 5.  Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy.

Authors:  Athanasios Tyraskis; Christopher Parsons; Mark Davenport
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14

6.  Improved outcome of biliary atresia with postoperative high-dose steroid.

Authors:  Rui Dong; Zai Song; Gong Chen; Shan Zheng; Xian-Min Xiao
Journal:  Gastroenterol Res Pract       Date:  2013-11-24       Impact factor: 2.260

Review 7.  Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy.

Authors:  Athanasios Tyraskis; Mark Davenport
Journal:  Pediatr Surg Int       Date:  2015-11-21       Impact factor: 1.827

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.